Submissions from 2023
Management of Brain Metastases: A Review of Novel Therapies, Shreyas Bellur, Atulya Khosla, Rupesh Kotecha, Michael McDermott, and Manmeet Ahluwalia
Tumor treating fields: narrative review of a promising treatment modality for cancer, Tugce Kutuk, Alonso La Rosa De Los Rios, Rupesh Kotecha, Minesh Mehta, and Michael Chuong
RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults, Minesh Mehta
A Multi-Institutional Phase II Trial of Ablative 5-Fraction Stereotactic MR-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer, Kathryn Mittauer and Michael Chuong
CTNI-08: Tucatinib, Trastuzumab, and Capecitabine with Stereotactic Radiosurgery in Patients with Brain Metastases from HER-2 Positive Breast Cancer (TUTOR): A Multicenter Phase 1 Clinical Trial, Manmeet Ahluwalia, Ahmad Ozair, Atulya Khosla, Shreyas Bellur, Rupesh Kotecha, Michael McDermott, Minesh Mehta, Ana Cristina Sandoval Leon, and Reshma Mahtani
CTNI-21: Phase I Study of BTK Inhibitor Ibrutinib with Temozolomide and Radiation in Newly-diagnosed Glioblastoma (EQUILIBRIUM): Final Trial Report, Manmeet Ahluwalia, Ahmad Ozair, and Atulya Khosla
DNAR-05: Exceptional Responders to Base Excision Repair (BER) Inhibition for Recurrent Glioblastoma Display Enrichment for DNA Damage Response Pathways: RNA Sequencing Analysis from a Multicenter Trial, Ahmad Ozair and Manmeet Ahluwalia
IMMU-02. Is Dual Agent Immunotherapy Shifting the Epidemiology of Melanoma Brain Metastases? A Real-World Analysis and Single-Institution Validation, Ahmad Ozair and Manmeet Ahluwalia
IMMU-34 Systemic Immune Suppression in Glioblastoma is Targeted by Concurrent VEGF and PD-1 Inhibition in a Dose-Dependent Manner: Transcriptomic Findings Through CITE-Seq from a Randomized Controlled Trial, Ahmad Ozair, Atulya Khosla, Shreyas Bellur, Michael McDermott, and Manmeet Ahluwalia
A study on inter-planner plan quality variability using a manual planning- or Lightning dose optimizer-approach for single brain lesions treated with the Gamma Knife(®) Icon™, Cecilia Lee, D Jay Wieczorek, Vibha Chaswal, Rupesh Kotecha, Matthew Hall, Minesh Mehta, Michael McDermott, Alonso Gutierrez, and Ranjini Tolakanahalli
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways, Minesh Mehta, Matthew Hall, Doured Daghistani, and Yazmin Odia
Clinical trial implementation: a primer for neurosurgeons, Rupesh Kotecha
Radiation induced taste changes in head and neck cancer - differential impact of treatment factors, Tiffany Nong, Tammy Medrano, Muni Rubens, Adeel Kaiser, and Noah Kalman
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling, Minesh Mehta
Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results, Guenther Koehne
Immune Checkpoint Inhibition and Single Fraction Stereotactic Radiosurgery in Brain Metastases from Non-Small Cell Lung Cancer: An International Multicenter Study of 395 Patients, Ahmad Ozair, Atulya Khosla, and Manmeet Ahluwalia
Integration and dosimetric validation of a dynamic collimation system for pencil beam scanning proton therapy, Alonso Gutiérrez
Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma, Manmeet Ahluwalia
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance, Noah Kalman and Sreenija Yarlagadda
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance, Noah Kalman and Sreenija Yarlagadda